Hyvönen P M, Karhi T, Kosma V M, Liimola-Luoma L, Hanhijärvi H
Department of Pharmacology and Toxicology, University of Kuopio, Finland.
Pharmacol Toxicol. 1994 Dec;75(6):384-90. doi: 10.1111/j.1600-0773.1994.tb00379.x.
The effects of dichloromethylene bisphosphonate (clodronate) on the composition of bone mineral, morphology and histology of a long bone with an artificial femoral fracture were studied in a 22 week experiment. Two hundred twenty-four female rats were allocated to dose groups of 0, 3, 10, and 30 mg/kg clodronate daily subcutaneously. Bone calcium, phosphorus and magnesium concentrations remained stable and fluoride concentration rose with time. There were no statistical differences between different groups. Clodronate did not alter the histology of the callus nor delayed the healing of the fracture. It caused mild to moderate prominence of the metaphyseal area in the fractured bone in a dose- and time-dependent manner. Serum osteocalcin levels were lowered in the treated animals dose-dependently. Other serological as well as haematological values were within normal range. Clodronate seems in this experimental arrangement to be a safe agent to administer in different pathological conditions of bone even when they are complicated by fractures of long bones.
在一项为期22周的实验中,研究了二氯亚甲基二膦酸盐(氯膦酸盐)对人工股骨骨折的长骨的骨矿物质组成、形态和组织学的影响。224只雌性大鼠被分配到每日皮下注射0、3、10和30mg/kg氯膦酸盐的剂量组。骨钙、磷和镁浓度保持稳定,氟浓度随时间升高。不同组之间无统计学差异。氯膦酸盐未改变骨痂的组织学,也未延迟骨折愈合。它以剂量和时间依赖性方式导致骨折骨的干骺端区域轻度至中度突出。治疗动物的血清骨钙素水平呈剂量依赖性降低。其他血清学和血液学值在正常范围内。在这种实验安排中,氯膦酸盐似乎是一种在不同骨病理状况下(即使伴有长骨骨折)给药的安全药物。